c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells

Molecular Cancer Therapeutics
Jaideep V ThottasseryWilliam B Parker

Abstract

Nucleoside anticancer drugs like gemcitabine (2'-deoxy-2',2'-difluorocytidine) are potent inducers of p53, and ectopic expression of wild-type p53 sensitizes cells to these agents. However, it is also known that nucleosides are efficient activators of apoptosis in tumor cells that do not express a functional p53. To clarify this issue, we examined the effects of gemcitabine and 4'-thio-beta-d-arabinofuranosylcytosine (T-ara-C) on p73, a structural and functional homologue of p53, whose activation could also account for nucleoside-induced apoptosis because no functionally significant mutations of p73 have been reported in cancers. Acute treatment of HCT 116 colon carcinoma cells with gemcitabine or T-ara-C induced marked cytotoxicity and cleavage of caspase-3 and poly(ADP-ribose) polymerase. T-ara-C and gemcitabine markedly induced p53 accumulation as well as increased levels of phospho-p53 (Ser15/Ser20/Ser46) and induced its binding to a consensus p53 response element. Despite robust activation of p53 by T-ara-C and gemcitabine, we found that wild-type and p53-/- HCT 116 cells exhibited almost equivalent sensitivity towards these nucleosides. Examination of p73 revealed that T-ara-C and gemcitabine markedly increased p73 protei...Continue Reading

References

Aug 1, 1991·Journal of Medicinal Chemistry·J A SecristJ A Montgomery
Sep 27, 1996·The Journal of Biological Chemistry·P PandeyS Kharbanda
Mar 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·R B GartenhausK R Rai
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·J V ThottasseryJ D Schuetz
Nov 26, 1998·The Journal of Biological Chemistry·P F LambertJ N Brady
Jan 16, 1999·Molecular and Cellular Biology·C J Di ComoC Prives
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·N H ChehabT D Halazonetis
Nov 4, 2000·Science·L ZhangB Vogelstein
Dec 8, 2000·Biochemical Pharmacology·W B ParkerJ A Secrist
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·V GottifrediC Prives
Feb 24, 2001·Nucleosides, Nucleotides & Nucleic Acids·K N TiwariJ A Secrist
Jan 10, 2002·Nature Cell Biology·Gabriella D'OraziSilvia Soddu
Feb 13, 2002·Oncogene·Ricardo Sanchez-PrietoJ Silvio Gutkind
Mar 5, 2002·The Journal of Biological Chemistry·Shin'ichi SaitoCarl W Anderson
Aug 3, 2002·Nature Reviews. Cancer·Gerry MelinoKaren H Vousden
Feb 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jian YuLin Zhang
Feb 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Hitoshi SomeyaWilliam B Parker
Apr 8, 2003·Cancer Chemotherapy and Pharmacology·William R WaudJohn A Secrist
May 3, 2003·Cancer Cell·Meredith S IrwinWilliam G Kaelin
Jul 16, 2003·The Journal of Biological Chemistry·Shin'ichi SaitoCarl W Anderson
Nov 25, 2003·The Journal of Biological Chemistry·Gerry MelinoKaren H Vousden
Mar 9, 2004·Biochemical and Biophysical Research Communications·Atsuya HabiroYutaka Kohgo
Jun 4, 2004·Molecular Cell·Fiamma MantovaniGiannino Del Sal
Jun 9, 2004·The Journal of Experimental Medicine·Francesca BernassolaPier Paolo Pandolfi
Dec 17, 2004·Genes & Development·Marshall UristCarol Prives
May 4, 2005·Biochemical and Biophysical Research Communications·Andrew OberstFrancesca Bernassola
May 4, 2005·Biochemical and Biophysical Research Communications·Saafa RamadanEleonora Candi
May 28, 2005·The Journal of Biological Chemistry·Iqbal Dulloo, Kanaga Sabapathy
Aug 30, 2005·Molecular Pharmacology·Larry M KarnitzScott H Kaufmann

❮ Previous
Next ❯

Citations

Nov 13, 2008·Cancer Chemotherapy and Pharmacology·William B ParkerWilliam R Waud
Dec 15, 2010·Stem Cells and Development·Chunhua LuRobert Chunhua Zhao
Feb 4, 2010·Molecular Cancer Therapeutics·Altaf A DarWael El-Rifai
Sep 20, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Anna VilgelmAlexander Zaika
Mar 27, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Salvatore V GiofrèMaria A Chiacchio
Mar 1, 2020·Cancers·Katarzyna MalarzRobert Musiol
Feb 6, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sonia RanaDavid N Wald
Jul 13, 2017·International Journal of Phytoremediation·Tanvi Singh, Dileep K Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

International Journal of Cancer. Journal International Du Cancer
Muriel VayssadeJean-Charles Ahomadegbe
Cancer Cell
Meredith S IrwinWilliam G Kaelin
Neoplasia : an International Journal for Oncology Research
Kai Wei LinKanaga Sabapathy
© 2021 Meta ULC. All rights reserved